Abstract
During the period from 1950 to 1952, three patients were studied by electrophoresis according to Tiselius on account of anticomplementary activity at WR; the presence of an M-component was demonstrated. On several later occasions it was observed that this component at first seemed to remain unchanged, later it was slightly increased; repeated examinations did not give evidence of multiple myeloma. At intervals ranging from 15 to 24 years after the primary demonstration of the M-component, all three patients presented with symptoms of multiple myeloma and died within less than one year after the disease had been diagnosed. The following conclusions are drawn:
(1) The preclinical phase of multiple myeloma may cover up to 24 years.
(2) A presence of multiple myeloma cannot be precluded, even after follow-up throughout 24 years, in cases of the so-called “benign monoclonal gammopathy”.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BICHEL J. MEGALOBLASTIC ANAEMIA AND MYXOEDEMA IN A PATIENT SUFFERING FROM MYELOMA, OBSERVED FOR A PERIOD OF 16 YEARS. Acta Med Scand. 1964 Aug;176:165–168. doi: 10.1111/j.0954-6820.1964.tb00922.x. [DOI] [PubMed] [Google Scholar]
- Hobbs J. R. Paraproteins. Proc R Soc Med. 1969 Aug;62(8):773–776. doi: 10.1177/003591576906200803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salmon S. E., Smith B. A. Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. J Clin Invest. 1970 Jun;49(6):1114–1121. doi: 10.1172/JCI106327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sleeper C. A., Cawley L. P. Detection and diagnosis of monoclonal gammopathy. Am J Clin Pathol. 1969 Mar;51(3):395–400. doi: 10.1093/ajcp/51.3.395. [DOI] [PubMed] [Google Scholar]